Victor J. Dzau
23 October 1945
|Residence||Durham, North Carolina|
|Alma mater||McGill University (BS, MD)|
|Known for||Development of angiotensin-converting-enzyme (ACE) inhibitors; Pioneer in gene therapy for vascular disease|
|Fields||Cardiovascular medicine and genetics|
|Institutions||Duke University (currently the James B. Duke Professor of Medicine)|
Victor Joseph Dzau PBM (Chinese: 曹文凱; pinyin: Cáo Wénkǎi; born 23 October 1945) is a Chinese-American doctor and academic. He serves as the President of the United States National Academy of Medicine (formerly the Institute of Medicine) of the United States National Academy of Sciences. He was previously the president and CEO of Duke University Medical Center.
Dzau was born in Shanghai, Republic of China. His father owned a chemical manufacturing company. He and his family fled to Hong Kong to escape from the Chinese Communist government. He received both his Bachelor of Science degree in Biology and his M.D. from McGill University in Montreal, Canada.
A leading cardiovascular scholar, Dzau was the Hersey Professor of the Theory and Practice of Medicine at Harvard Medical School and served as Chairman of the Department of Medicine at Harvard Medical School's Brigham and Women's Hospital, as well as Chairman of the Department of Medicine at Stanford University. He then became the Chancellor for Health Affairs at Duke University and President and CEO of the Duke University Medical Center. Dzau is currently the James B. Duke Professor of Medicine at Duke University. In July 2014, he was elected for a six-year term (renewable) as President of the then Institute of Medicine (now the National Academy of Medicine). He is a member of the National Academy of Medicine, The American Academy of Arts and Sciences, and the European Academy of Sciences and Arts. He was the previous Chairman of the National Institutes of Health (NIH) Cardiovascular Disease Advisory Committee, and he served on the Advisory Committee to the Director of NIH.
Dzau has made a significant impact on medicine through seminal research in cardiovascular medicine and genetics, his pioneering work in the discipline of vascular medicine, and his leadership in health care innovation. His seminal research laid the foundation for the development of angiotensin-converting-enzyme (ACE) inhibitors, which are used globally for the treatment of high blood pressure and congestive heart failure. He pioneered gene therapy for vascular disease, being the first to introduce DNA decoy molecules to block transcriptions as gene therapy in humans.
Dzau's wife, Ruth, is the president of The Second Step, a nonprofit charitable organization that provides housing and transnational programs for domestic violence victims. They have two daughters, Jacqueline and Merissa. Dzau is on the honor roll of the Jewish Federation of Durham Chapel Hill and has been a speaker at the Federation's Ignite talks.
Honors and awards
- Eight honorary doctorate degrees.
- 2004 Named Distinguished Scientist of the American Heart Association
- 2004 Max Delbrück Medal, Berlin, Germany
- 2005 Ellis Island Medal of Honor
- 2012 Henry Freisen International Prize
- 2014 Singapore Public Service Medal
- "香港大學名譽博士學位畢業生 - 曹文凱". Hong Kong University. Retrieved 2018-10-12.
- "Institute of Medicine to Become National Academy of Medicine". Archived from the original on 28 April 2015.
- Watts, Geoff (2014). "Victor Dzau: Change and controversy at the Institute of Medicine". The Lancet. 383 (9936): 2203. doi:10.1016/S0140-6736(14)61073-4.
- "Victor Dzau, M.D." Archived from the original on February 11, 2005. Retrieved 20 February 2013.
- Husten, Larry. "Victor Dzau Leaving Duke To Head The Institute Of Medicine".
- "Dzaus Kick Off We Build People Campaign - YMCA". www.ymcatriangle.org.
- "Victor J. Dzau, MD, Selected to Lead Duke University Health System".
- Becker, Sheldon (8 March 2014). "Dr Dzau: From Cancer to Community - The Future of Healthcare Systems and Hospitals" – via Vimeo.
- "2013 Honor Roll - Jewish Federation of Durham-Chapel Hill".